Description

Diagnostics are the crucial link between the two key strategies for good health, prevention and treatment. Animal diagnostics are critical for animal health, identifying health issues before they are otherwise able to be detected and supporting faster diagnosis and treatment planning. The global animal therapeutics and diagnostics market is poised to grow by US$ 22.5 billion during 2022-2028, progressing at a CAGR of 6.1% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for animal therapeutics and diagnostics. The global animal therapeutics and diagnostics market is segmented on the basis of product, end user, and region. By product, the global animal therapeutics and diagnostics market has been segmented into diagnostics, feed additives, therapeutics, vaccines. According to the research, the therapeutics segment had the largest share in the global animal therapeutics and diagnostics market. Based upon end user, the global animal therapeutics and diagnostics market is categorized into companion animals, production animals. In 2021, the production animals segment made up the largest share of revenue generated by the animal therapeutics and diagnostics market. Geographically, the global animal therapeutics and diagnostics market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW). Among these, North America was accounted for the highest revenue generator in 2021.

The diagnostics market is further segmented into analyzers and consumables, imaging equipment and related, and rapid test kits. StrategyHelix research indicates that the analyzers and consumables segment occupied the largest share of this market in 2021 and is expected to draw the highest demand in coming years. Furthermore, the pharmaceuticals/therapeutics market has been categorized into allergy and respiratory drugs, anti-infectives, anti-inflammatories and analgesics, metabolic drugs, parasiticides, psychotropics, and others. Globally, the parasiticides segment made up the largest share of the animal therapeutics and diagnostics market. The feed additives market is further divided into amino acids, medicinal additives, nutritional supplements, and vitamins and minerals. The amino acids segment was the largest contributor to the global animal therapeutics and diagnostics market in 2021.

The global animal therapeutics and diagnostics market is highly competitive. The prominent players operating in the global animal therapeutics and diagnostics market include Ajinomoto Co. Inc., BASF SE, Bayer AG, Boehringer Ingelheim GmbH, China National BlueStar (Group) Co Ltd., DSM Nutritional Products AG, Elanco Animal Health Incorporated, Evonik Industries AG, IDEXX Laboratories Inc., Merck Animal Health, The Mosaic Company, Virbac SA, Zoetis Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the animal therapeutics and diagnostics market to help drive informed decision making for industry executives, policy makers, academic, and analysts.


Report Scope

Product: diagnostics, feed additives, therapeutics, vaccines
End user: companion animals, production animals
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028


Key Benefits for Stakeholders

– Get a comprehensive picture of the global animal therapeutics and diagnostics market
– Pinpoint growth sectors and trends for investment


Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Animal therapeutics and diagnostics market overview
Part 3. Market breakdown by product
– Diagnostics
– Feed additives
– Therapeutics
– Vaccines
Part 4. Market breakdown by end user
– Companion animals
– Production animals
Part 5. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 6. Key companies
– Ajinomoto Co., Inc.
– BASF SE
– Bayer AG
– Boehringer Ingelheim GmbH
– China National BlueStar (Group) Co, Ltd.
– DSM Nutritional Products AG
– Elanco Animal Health Incorporated
– Evonik Industries AG
– IDEXX Laboratories, Inc.
– Merck Animal Health
– The Mosaic Company
– Virbac SA
– Zoetis Inc.
About StrategyHelix
Disclaimer


USD 650

Product Type

Industry Statistics

Release Date

May 2022

Region

Global

Pages

15

REQUEST SAMPLE

Global Animal Therapeutics and Diagnostics Market 2022

Please fill out our form and we will get back to you.

CUSTOM RESEARCH

Global Animal Therapeutics and Diagnostics Market 2022

Please fill out our form and we will get back to you.

login